BFC Planning’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
BFC Planning's BEAM Position: Q3 2026 in Review
BFC Planning opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 27 shares worth $660. The stake represents ﹤0.01% of the portfolio and ranks #3246 among its holdings.
191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- BFC Planning held 27 shares of Beam Therapeutics worth $660 as of Q3 2026.
- Beam Therapeutics was a new BFC Planning position in Q3 2026.
- Beam Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3246 holding.
- 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.